Books > Medicine > Clinical & internal medicine > Renal medicine
|
Buy Now
Treatment of Primary Glomerulonephritis (Paperback, 3rd Revised edition)
Loot Price: R2,221
Discovery Miles 22 210
|
|
Treatment of Primary Glomerulonephritis (Paperback, 3rd Revised edition)
Series: Oxford Clinical Nephrology Series
Expected to ship within 12 - 17 working days
|
Primary glomerulonephritis is one of the most frequent renal
diseases, and a main cause of end-stage kidney disease.
Glomerulonephritis has multiple subtypes, each with different
physiopathologies, clinical presentations, and management
requirements, which makes treatment difficult. As a complex set of
diseases, the choice of symptomatic and specific treatment is
critical to ameliorating the relentless course of
glomerulonephritis. Focusing on all aspects of primary
glomerulonephritis, from their epidemiologies and classification,
to their pathogenesis and treatment, this third edition of
Treatment of Primary Glomerulonephritis has been fully updated to
include the latest research and evidence-based practice. With a
strong emphasis on drugs used for both symptomatic and specific
treatments, mechanisms of action, effectiveness, and potential
toxicity are considered for therapeutic strategies in the different
subtypes of primary glomerulonephritis. Each chapter follows a
clear and logical format, allowing easy access to key information.
Featuring over 20 full-colour histological images of different
diseases to aid diagnosis, and with commentary from internationally
recognised experts in the field, this new edition is an essential
resource for all practising or academic clinical nephrologists.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.